Patents-Review.com
ClassID:

111672 ⎘

C12N2770/36123 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Togaviridae; Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki Virus like particles [VLP]

Recent Application in this class:
#1
20260152728
2026-06-04

VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE

 #2
20260034208
2026-02-05

VIRUS-LIKE VESICLES (VLVS) BASED VACCINES AND METHODS OF PREVENTING, AMELIORATING, AND/OR TREATING COVID-19 AND/OR HEPATOCELLULAR CARCINOMA (HCC)

 #3
20250326801
2025-10-23

VIRUS-LIKE PARTICLES AND METHODS OF USE

 #4
20250129342
2025-04-24

ALPHAVIRUS REPLICON PARTICLE

 #5
20250073326
2025-03-06

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

 #6
20240398921
2024-12-05

VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASES AND CANCER IMMUNOTHERAPY APPLICATIONS

 #7
20240307520
2024-09-19

Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins

 #8
20240277836
2024-08-22

Self-Amplifying RNA-Based VLP Vaccines

 #9
20240018191
2024-01-18

CHIMERIC CORONAVIRUS S PROTEIN COMPOSITIONS AND METHODS OF USE

 #10
20230295242
2023-09-21

Virus-like particles and methods of use

 #11
20230293661
2023-09-21

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

 #12
20230257775
2023-08-17

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

 #13
20230025038
2023-01-26

Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins

 #14
20220024989
2022-01-27

Alphavirus nsP mutants as vaccines

 #15
20220016230
2022-01-20

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

 #16
20220002682
2022-01-06

Alphavirus replicon particle

 #17
20210388034
2021-12-16

Virus-like particles and methods of use

 #18
20210347863
2021-11-11

Nucleic acids encoding single domain antibodies to chikungunya virus

 #19
20210322534
2021-10-21

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

 #20
20210322529
2021-10-21

Cancer vaccines and methods of producing and using same

 #21
20210163988
2021-06-03

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

 #22
20210163544
2021-06-03

Stable cell line secreting Chikungunya Virus (CHIKV) virus like particles (VLP) for vaccines

 #23
20200368344
2020-11-26

CHIKV RNA vaccines

 #24
20200172930
2020-06-04

Chikungunya virus antigen constructs

 #25
20200121774
2020-04-23

CANCER VACCINES AND METHODS OF PRODUCING AND USING SAME

 #26
20200102545
2020-04-02

DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS

 #27
20200085938
2020-03-19

Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

 #28
20200024331
2020-01-23

Single domain antibodies to Chikungunya virus

 #29
20190359656
2019-11-28

Alphavirus NSP mutants as vaccines

 #30
20190185822
2019-06-20

ALPHAVIRUS REPLICON PARTICLE

 #31
20190153041
2019-05-23

Virus-like particles and methods of use

 #32
20190060438
2019-02-28

Infectious disease vaccines

 #33
20180344839
2018-12-06

CHIKV RNA vaccines

 #34
20180280496
2018-10-04

Zika RNA vaccines

 #35
20170233450
2017-08-17

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

 #36
20170096455
2017-04-06

Methods and compositions for chimeric coronavirus spike proteins

 #37
20170073377
2017-03-16

Virus-like particles and methods of use

 #38
20170065703
2017-03-09

Method and composition for modulating immune response

 #39
20170035871
2017-02-09

MALARIA VACCINE

 #40
20160348132
2016-12-01

TC-83-derived alphavirus vectors, particles and methods

 #41
20160340653
2016-11-24

Delivery of packaged RNA to mammalian cells

 #42
20160312242
2016-10-27

CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON

 #43
20160303221
2016-10-20

Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

 #44
20160200775
2016-07-14

Virus like particle comprising modified envelope protein E3

 #45
20160145323
2016-05-26

Antibodies against chikungunya virus and uses thereof

 #46
20160090403
2016-03-31

Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein

 #47
20160040134
2016-02-11

Virus like particle comprising modified envelope protein E3

 #48
20150238592
2015-08-27

Recombinant measles virus expressing chikungunya virus polypeptides and their applications

 #49
20150050243
2015-02-19

Delivery of packaged RNA to mammalian cells

 #50
20150017194
2015-01-15

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

 #51
20140170186
2014-06-19

Virus-like particles and methods of use

 #52
20140120125
2014-05-01

Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation

 #53
20140065178
2014-03-06

Methods and compositions for pseudoinfectious alphaviruses

 #54
20130251744
2013-09-26

Virus like particle composition

 #55
20120003266
2012-01-05

Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

 #56
20110027306
2011-02-03

TC-83-derived alphavirus vectors, particles and methods

 #57
20100040650
2010-02-18

Virus-Like paramyxovirus particles and vaccines

 #58
20100034843
2010-02-11

Immunogenic compositions and vaccines for Ebola

 #59
20060257889
2006-11-16

Ribonuclease resistant RNA preparation and utilization

 #60
20060251681
2006-11-09

Methods for producing Marburg virus proteins

 #61
20060228376
2006-10-12

Virosome-like-particles

 #62
20050266550
2005-12-01

TC-83-derived alphavirus vectors, particles and methods